PeptideBase
Back to Database
evidence varies by claim

Exenatide

Exenatide

Metabolic & Endocrine

Exenatide is indexed as peptide in the PeptideBase article library. It is referenced in “GLP-1 Drugs and Gastroparesis: What 13 Published Cases Can—and Cannot—Show”. This page groups the relevant coverage; evidence strength, safety, and clinical relevance depend on the specific claim and source.

Research status: evidence varies by claim

Deep Dives on Exenatide

Start here for the plain-English articles connected to this peptide.

Research & Evidence9 min read

GLP-1 Drugs and Gastroparesis: What 13 Published Cases Can—and Cannot—Show

A 2026 systematic review found only 12 case reports describing 13 patients. Here is what that GLP-1 gastroparesis evidence signals—and why it cannot establish incidence, causality, or comparative drug risk.

Read article

Quick Facts

Origin
Named peptide referenced in PeptideBase coverage
Category
Metabolic & Endocrine

Research Areas

Research & Evidence

Tags

exenatidepeptidenamed peptide